Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Staar Surgical Company (STAA)

Staar Surgical Company (STAA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,094,821
  • Shares Outstanding, K 49,742
  • Annual Sales, $ 313,900 K
  • Annual Income, $ -20,210 K
  • EBIT $ -97 M
  • EBITDA $ -91 M
  • 60-Month Beta 1.00
  • Price/Sales 4.72
  • Price/Cash Flow N/A
  • Price/Book 3.09

Options Overview Details

View History
  • Implied Volatility 62.30% (-3.45%)
  • Historical Volatility 57.88%
  • IV Percentile 27%
  • IV Rank 42.42%
  • IV High 135.13% on 04/16/25
  • IV Low 8.65% on 08/12/25
  • Expected Move (DTE 3) 2.13 (10.06%)
  • Put/Call Vol Ratio 2.63
  • Today's Volume 980
  • Volume Avg (30-Day) 1,318
  • Put/Call OI Ratio 1.98
  • Today's Open Interest 20,651
  • Open Int (30-Day) 28,685
  • Expected Range 19.01 to 23.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate -0.04
  • Prior Year -0.59
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.82 +6.61%
on 01/06/26
26.18 -19.29%
on 12/17/25
-3.00 (-12.43%)
since 12/12/25
3-Month
19.82 +6.61%
on 01/06/26
28.40 -25.60%
on 11/24/25
-6.12 (-22.46%)
since 10/13/25
52-Week
13.50 +56.52%
on 02/12/25
30.81 -31.42%
on 08/13/25
-1.35 (-6.01%)
since 01/13/25

Most Recent Stories

More News
3 Stocks Under $50 That Fall Short

3 Stocks Under $50 That Fall Short

KMX : 46.45 (+3.91%)
STAA : 21.13 (-4.00%)
PLAB : 33.39 (-0.92%)
Alcon Terminates Agreement to Acquire STAAR Surgical

Ad hoc announcement pursuant to Art. 53 LR

STAA : 21.13 (-4.00%)
ALC : 78.99 (-2.31%)
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

Thanks Fellow Shareholders for Rejecting the Transaction Reiterates Enthusiasm for the Company’s Standalone Prospects ...

STAA : 21.13 (-4.00%)
ALC : 78.99 (-2.31%)
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

STAAR Intends to Terminate Alcon Merger Agreement

STAA : 21.13 (-4.00%)
3 Low-Volatility Stocks We Keep Off Our Radar

3 Low-Volatility Stocks We Keep Off Our Radar

TOL : 148.81 (+1.27%)
ABR : 7.75 (-0.77%)
STAA : 21.13 (-4.00%)
3 Cash-Heavy Stocks We Keep Off Our Radar

3 Cash-Heavy Stocks We Keep Off Our Radar

EWBC : 114.45 (-0.52%)
STAA : 21.13 (-4.00%)
SSYS : 9.99 (-4.13%)
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon

Urges Board to Allow Shareholders to Have Their Final Say on This Ill-Conceived Transaction

STAA : 21.13 (-4.00%)
ALC : 78.99 (-2.31%)
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

STAAR Special Meeting of Stockholders Adjourned to January 6, 2026

STAA : 21.13 (-4.00%)
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal

STAA : 21.13 (-4.00%)
ALC : 78.99 (-2.31%)
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

Expresses Confidence in STAAR’s Future and the Opportunity for Significant Value Creation Believes STAAR is Worth at Least $50 Per Share If the Company...

STAA : 21.13 (-4.00%)
ALC : 78.99 (-2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

See More

Key Turning Points

3rd Resistance Point 23.21
2nd Resistance Point 22.94
1st Resistance Point 22.48
Last Price 21.13
1st Support Level 21.75
2nd Support Level 21.48
3rd Support Level 21.02

See More

52-Week High 30.81
Fibonacci 61.8% 24.20
Fibonacci 50% 22.15
Last Price 21.13
Fibonacci 38.2% 20.11
52-Week Low 13.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar